Page last updated: 2024-11-07

methacetin and Diabetes Mellitus, Type 2

methacetin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

methacetin: RN given refers to parent cpd
methacetin : A member of the class of acetamides that is paracetamol in which the hydrogen of phenolic hydroxy group has been replaced by a methyl group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Overweight, obesity and liver fat accumulation manifest with deranged portal extraction efficiency of methacetin into the steatotic hepatocyte."4.31Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease. ( Andrade, R; Bonfrate, L; Di Ciaula, A; Macedo, MP; Pina, A; Portincasa, P; Raposo, JF; Ribeiro, R; Shanmugam, H, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Di Ciaula, A1
Shanmugam, H1
Ribeiro, R1
Pina, A1
Andrade, R1
Bonfrate, L1
Raposo, JF1
Macedo, MP1
Portincasa, P1

Other Studies

1 other study available for methacetin and Diabetes Mellitus, Type 2

ArticleYear
Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
    European journal of internal medicine, 2023, Volume: 107

    Topics: Biomarkers; Diabetes Mellitus, Type 2; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Dis

2023